目次
1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. ソース別スニペット
3.2. 形式別スニペット
3.3. アプリケーション別スニペット
3.4. 販売チャネル別スニペット
3.5. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 各社の開発戦略
4.1.1.2. 天然抗酸化剤と持続可能な養殖方法に対する需要の高まり
4.1.2. 阻害要因
4.1.2.1. 高い生産コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. ロシア・ウクライナ戦争の影響分析
5.6. SWOT分析
5.7. バリューチェーン分析
5.8. 市場参入戦略
5.9. 輸出入分析
5.10. 消費者分析
5.10.1. 消費者のペインポイント
5.10.2. 消費者ニーズ
5.11. 臨床試験データ
5.12. DMI意見
6. 情報源別
6.1. はじめに
6.1.1. ソース別市場規模分析および前年比成長率分析（%）.
6.1.2. 市場魅力度指数, 供給源別
6.2. 微細藻類
6.2.1. 序論
6.2.1.1. 市場規模分析と前年比成長率分析(%)
6.2.2. 酵母
6.2.3. 甲殻類
6.2.4. その他
7. 形態別
7.1. 導入
7.1.1. 市場規模分析および前年比成長率分析（%）, 形態別
7.1.2. 市場魅力度指数（形態別
7.2. 粉末*市場
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 液体
7.4. カプセル/錠剤
7.5. その他
8. 用途別
8.1. 導入
8.1.1. 用途別市場規模分析および前年比成長率分析(%)
8.1.2. 市場魅力度指数、用途別
8.2. 栄養補助食品
8.2.1. 序論
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 化粧品とパーソナルケア
8.4. 食品・飲料
8.5. 飼料
8.6. 医薬品
8.7. その他
9. 販売チャネル別
9.1. はじめに
9.1.1. 市場規模分析および前年比成長率分析（%）, 販売チャネル別
9.1.2. 市場魅力度指数（販売チャネル別
9.2. B2B*市場
9.2.1. はじめに
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. B2C
10. サステナビリティ分析
10.1. 環境分析
10.2. 経済分析
10.3. ガバナンス分析
11. 地域別
11.1. はじめに
11.1.1. 地域別市場規模分析および前年比成長率分析(%)
11.1.2. 市場魅力度指数、地域別
11.2. 北米
11.2.1. 序論
11.2.2. 主な地域別ダイナミクス
11.2.3. 市場規模分析およびYoY成長率分析(%), 供給源別
11.2.4. 市場規模分析および前年比成長率分析（%）, フォーム別
11.2.5. 市場規模分析および前年比成長率分析（%）, 用途別
11.2.6. 市場規模分析および前年比成長率分析（%）, 販売チャネル別
11.2.7. 市場規模分析および前年比成長率分析（%）, 国別
11.2.7.1. 米国
11.2.7.2. カナダ
11.2.7.3. メキシコ
11.3. ヨーロッパ
11.3.1. はじめに
11.3.2. 主な地域別動向
11.3.3. 市場規模分析およびYoY成長率分析(%), 供給源別
11.3.4. 市場規模分析および前年比成長率分析（%）, フォーム別
11.3.5. 市場規模分析および前年比成長率分析（%）, 用途別
11.3.6. 市場規模分析および前年比成長率分析（%）, 販売チャネル別
11.3.7. 市場規模分析および前年比成長率分析（%）, 国別
11.3.7.1. ドイツ
11.3.7.2. イギリス
11.3.7.3. フランス
11.3.7.4. イタリア
11.3.7.5. スペイン
11.3.7.6. その他のヨーロッパ
11.3.8. 南米
11.3.9. はじめに
11.3.10. 市場規模分析およびYoY成長率分析(%), 発生源別
11.3.11. 市場規模分析と前年比成長率分析（%）, 形状別
11.3.12. 市場規模分析および前年比成長率分析（%）, 用途別
11.3.13. 市場規模分析および前年比成長率分析（%）, 販売チャネル別
11.3.14. 市場規模分析および前年比成長率分析（%）, 国別
11.3.14.1. ブラジル
11.3.14.2. アルゼンチン
11.3.14.3. その他の南米地域
11.4. アジア太平洋
11.4.1. はじめに
11.4.2. 主な地域別ダイナミクス
11.4.3. 市場規模分析およびYoY成長率分析(%), 供給源別
11.4.4. 市場規模分析および前年比成長率分析（%）, フォーム別
11.4.5. 市場規模分析および前年比成長率分析 (%)、用途別
11.4.6. 市場規模分析および前年比成長率分析（%）, 販売チャネル別
11.4.7. 市場規模分析および前年比成長率分析（%）, 国別
11.4.7.1. 中国
11.4.7.2. インド
11.4.7.3. 日本
11.4.7.4. オーストラリア
11.4.7.5. その他のアジア太平洋地域
11.5. 中東・アフリカ
11.5.1. 序論
11.5.2. 主な地域別ダイナミクス
11.5.3. 市場規模分析および前年比成長率分析(%)、供給源別
11.5.4. 市場規模分析および前年比成長率分析（%）, フォーム別
11.5.5. 市場規模分析および前年比成長率分析（%）, 用途別
11.5.6. 市場規模分析および前年比成長率分析（%）, 販売チャネル別
12. 競争環境
12.1. 競争シナリオ
12.2. 市場ポジショニング／シェア分析
12.3. M&A分析
13. 企業プロフィール
13.1. Algalif*
13.1.1. 会社概要
13.1.2. 製品ポートフォリオと内容
13.1.3. 財務概要
13.1.4. 主な展開
13.2. Cyanotech Corporation
13.3. AstaReal
13.4. Valensa International
13.5. Atcama BIO
13.6. Algatech LTD
13.7. Piveg
13.8. Cardax, Inc
13.9. Xi’an Healthful Biotechnology Co.,Ltd
13.10. Algae Health Sciences
リストは網羅的ではありません
14. 付録
14.1. 会社概要とサービス
14.2. お問い合わせ

Overview
Global Natural Astaxanthin Market reached US$ 0.84 billion in 2023 and is expected to reach US$ 1.5 billion by 2031, growing with a CAGR of 7.7% during the forecast period 2024-2031.

The natural astaxanthin market is experiencing significant growth, driven by the rising demand for natural antioxidants across various sectors such as nutraceuticals, cosmetics, food & beverages and animal feed. Natural astaxanthin, primarily derived from Haematococcus pluvialis microalgae, is renowned for its potent antioxidant properties, offering health benefits such as anti-aging effects, enhanced immune response, improved skin health and protection against oxidative stress.
This has led to its increasing utilization in dietary supplements and functional foods, particularly among health-conscious consumers and the aging population who seek natural solutions for chronic health conditions and general well-being. The nutraceuticals segment is driving market growth due to the rising demand for natural antioxidants, health-conscious consumer trends and the expanding applications of astaxanthin in functional foods, dietary supplements and sports nutrition.
In North America, there's a growing consumer shift towards natural, health-enhancing products, driven by increased awareness of the health benefits of antioxidants. Natural astaxanthin, known for its anti-inflammatory and anti-aging properties, is gaining attention in dietary supplements, functional foods and beverages. With growing interest in natural health solutions, sustainability and preventive healthcare, the natural astaxanthin market is poised for robust growth in the coming years, especially in emerging markets where health and wellness trends are gaining traction.

Dynamics
Development Strategies Adopted by the Companies
Strategies like partnerships, product launches and expansions are pivotal in accelerating the growth of the natural astaxanthin market. These strategies help companies tap into new markets, enhance product offerings and improve production capacities. For instance, in 2024, AgroSystems (“KAS”), a leading microalgal innovation and production company, had raised a $3 million Series A2 funding round led by S2G Ventures. The funding will accelerate the commercialization of KAS’s pioneering method for producing natural astaxanthin from microalgae, a key component in sustainable aquaculture systems as well as a clinically proven human nutraceutical. KAS has patented an innovative process that uses dark fermentation in closed vertical tank systems to produce high-quality natural algae astaxanthin.
Additionally, in 2024, AstaReal, global pioneer in production and research of natural algal astaxanthin, had launched a rebranded version of its finished formulation Astaxin for consumers in Sweden and Norway. In addition to online stores and health food stores, the supplement is also now available in selected pharmacies. Moreover, in 2023, AstaReal had started a new partnership with raw material distributor C.F.M. Co. Farmaceutica Milanese. After the partnership, nutraceutical producers in Italy who wish to include AstaReal natural astaxanthin in their formulations will receive professional technical, regulatory, scientific and logistical support.

Rising Demand for Natural Antioxidants and Sustainable Aquaculture Practices
The natural astaxanthin market is primarily driven by the increasing demand for natural antioxidants in the dietary supplement, cosmetic and food & beverage industries. The increasing popularity of clean-label and natural ingredients among consumers has led manufacturers to include natural astaxanthin, valued for its powerful antioxidant properties and benefits for eye health, anti-aging and skin protection.
Global Organization for EPA and DHA Omega-3s (GOED) noticed, the dietary supplement sector, where natural astaxanthin is frequently used, saw substantial growth in 2023, with a rising focus on ingredients that support eye health and skin care. The increasing consumer knowledge and desire for ingredients sourced sustainably and environmentally friendly are also strengthening the market.
Another key driver is the rising use of natural astaxanthin in aquaculture, particularly in salmon farming, to enhance the pigmentation and overall health of farmed fish. According to the Food and Agriculture Organization (FAO), Global fisheries and aquaculture production in 2022 surged to 223.2 million tonnes, a 4.4 percent increase from the year 2020. with astaxanthin being a critical component in fish feed due to its coloring and antioxidant benefits.
Additionally, the shift towards sustainable aquaculture practices and the reduction of synthetic additives have led to an increased preference for natural alternatives like astaxanthin. This trend aligns with the global movement towards eco-friendly and health-conscious products, further supporting market expansion.

High Production Costs
High production costs are a significant restraining factor for the natural astaxanthin market, affecting the profitability and competitiveness of products derived from this valuable carotenoid. The production of natural astaxanthin primarily involves the cultivation of microalgae, such as Haematococcus pluvialis, which is renowned for its ability to produce astaxanthin in high concentrations. This cultivation requires specific environmental conditions, including optimal light, temperature and nutrient availability, which can lead to increased operational costs.
For instance, according to National Library of Medicine, 2021, stated that, the high production cost of natural astaxanthin as well as several technological problems (that are common to all microalga derived products) are currently limiting the mass production of this ingredient. For example, the cost of producing natural astaxanthin using the microalga H. pluvialis in the EU is approximately US$ 1672.88/ Kg.

Segment Analysis
The global natural astaxanthin market is segmented based on Source, Form, Application, Sales Channel and Region.
Market Growth in Nutraceuticals Driven by Astaxanthin Demand and Innovations
The nutraceuticals segment is driving market growth due to the rising demand for natural antioxidants, health-conscious consumer trends and the expanding applications of astaxanthin in functional foods, dietary supplements and sports nutrition. Nutraceutical companies are increasingly forming alliances with research institutions and biotechnology firms to improve astaxanthin extraction technologies and develop innovative product formulations.
Additionally, there is a growing trend towards natural, plant-based and sustainable ingredients in the nutraceuticals market. Natural astaxanthin, derived from sources like microalgae (Haematococcus pluvialis), appeals to consumers who prefer natural alternatives over synthetic antioxidants. With its strong scientific backing and expanding applications across functional foods, supplements and sports nutrition, natural astaxanthin is poised to play a significant role in the future of the nutraceuticals market.

Geographical Penetration
High Demand for Natural Astaxanthin from North America
In North America, there's a growing consumer shift towards natural, health-enhancing products, driven by increased awareness of the health benefits of antioxidants. Natural astaxanthin, known for its anti-inflammatory and anti-aging properties, is gaining attention in dietary supplements, functional foods and beverages.
For instance, in 2024, the US-based chemical vendor Alfa Chemistry had launched of a series of premium natural astaxanthin ingredients aimed at improving health and well-being. Astaxanthin, a powerful antioxidant with numerous health benefits, is known for its ability to support cardiovascular health, skin health and eye health, among other things.
Additionally, US organic retails sales increased by an average of 8 percent per year. In 2021 organic retail sales were estimated to be more than US$ 52 billion, about 5.5 percent of all retail food sales. US farms and ranches sold nearly US$ 11 billion in organic products in 2021. Imports also are helping to meet consumer demand.
Moreover, North America's relatively favourable regulatory framework for dietary supplements and natural ingredients has also facilitated the growth of the natural astaxanthin market. For instance, astaxanthin from algae, synthetic and bacterial sources is generally recognized as safe in US. Additionally, the rise in distribution of natural astaxanthin products in the region across various platforms, combined with strong consumer interest in natural, safe and effective ingredients, continue to drive growth in this region.

Competitive Landscape
The major global players in the market include Algalif, Cyanotech Corporation, AstaReal, Valensa International, Atcama BIO, Algatech LTD, Piveg, Cardax, Inc, Xi'an Healthful Biotechnology Co., Ltd and Algae Health Sciences.

Sustainability Analysis
The sustainable growth of the natural astaxanthin market is primarily driven by its increasing demand in the nutraceutical and aquaculture sectors. The Global Organization for EPA and DHA Omega-3s (GOED) has noted an increase in consumer demand for natural antioxidants, with a preference for natural astaxanthin over synthetic forms because of its environmentally friendly production process.
Companies are investing in sustainable production methods, such as cultivating Haematococcus pluvialis microalgae in controlled environments, which significantly reduces the environmental impact compared to synthetic astaxanthin production. As stated by the Algae Biomass Organization, this approach aids in carbon sequestration and reduces water consumption, in line with worldwide sustainability objectives.
In the food and beverage sector, sustainable sourcing methods are becoming more popular, driven by consumer desire for natural, trackable components. Industry groups such as NAXA stress that natural astaxanthin producers are more and more utilizing renewable energy and closed-loop systems to improve sustainability.
Additionally, the use of non-genetically modified strains in cultivation ensures adherence to organic standards, further boosting its appeal among health-conscious consumers. This sustainable approach not only enhances the product's marketability but also helps companies meet regulatory requirements for eco-labeling, driving market growth.

By Source
• Microalgae
• Yeast
• Crustaceans
• Others
By Form
• Powder
• Liquid
• Capsule/Tablets
• Others
By Applications
• Nutraceuticals
• Cosmetics and Personal Care
• Food & Beverages
• Feed
• Pharmaceuticals
• Others
By Sales Channel
• B2B
• B2C
Region
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• In May 2024, Divi's Nutraceuticals, an American company, introduced AstaBead, a sustainable astaxanthin beadlet product, at Vitafoods 2024 in Switzerland. AstaBead is created in partnership with Algalif and makes use of Algalif's manufacturing plant in Iceland, running entirely on renewable energy, highlighting a focus on sustainability.
• In April 2024, Alfa Chemistry, a chemical supplier from US, launched a new range of high-quality natural astaxanthin ingredients designed to improve health and wellness. This release demonstrates the company's commitment to broadening its product range in the nutraceutical industry.
• In February 2024, AstaReal, a top Swedish company in astaxanthin manufacturing, renamed its Astaxin Original product and unveiled intentions to introduce a vegan option in the European market shortly. AstaReal showcased the renamed product at the Fi Europe event in Frankfurt in late 2023, emphasizing its dedication to creativity and meeting various consumer tastes.

Why Purchase the Report?
• To visualize the global natural astaxanthin market segmentation based on source, form, application, sales channel and region.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points at the natural astaxanthin market level for all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global natural astaxanthin market report would provide approximately 70 tables, 66 figures and 215 pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Source
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by Sales Channel
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Development Strategies Adopted by the Companies
4.1.1.2. Rising Demand for Natural Antioxidants and Sustainable Aquaculture Practices
4.1.2. Restraints
4.1.2.1. High Production Costs
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Value Chain Analysis
5.8. GO-TO-Market Strategy
5.9. Import and Export Analysis
5.10. Consumer Analysis
5.10.1. Consumer Pain Points
5.10.2. Consumer Needs
5.11. Clinical Trial Data
5.12. DMI Opinion
6. By Source
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
6.1.2. Market Attractiveness Index, By Source
6.2. Microalgae*
6.2.1. Introduction
6.2.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.2. Yeast
6.2.3. Crustaceans
6.2.4. Others
7. By Form
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
7.1.2. Market Attractiveness Index, By Form
7.2. Powder*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Liquid
7.4. Capsule/Tablets
7.5. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Nutraceuticals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cosmetics and Personal Care
8.4. Food & Beverages
8.5. Feed
8.6. Pharmaceuticals
8.7. Others
9. By Sales Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
9.1.2. Market Attractiveness Index, By Sales Channel
9.2. B2B*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. B2C
10. Sustainability Analysis
10.1. Environmental Analysis
10.2. Economic Analysis
10.3. Governance Analysis
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. US
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.3.8. South America
11.3.9. Introduction
11.3.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.3.11. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.3.12. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.13. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
11.3.14. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.14.1. Brazil
11.3.14.2. Argentina
11.3.14.3. Rest of South America
11.4. Asia-Pacific
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. China
11.4.7.2. India
11.4.7.3. Japan
11.4.7.4. Australia
11.4.7.5. Rest of Asia-Pacific
11.5. Middle East and Africa
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Algalif*
13.1.1. Company Overview
13.1.2. Type Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Cyanotech Corporation
13.3. AstaReal
13.4. Valensa International
13.5. Atcama BIO
13.6. Algatech LTD
13.7. Piveg
13.8. Cardax, Inc
13.9. Xi'an Healthful Biotechnology Co.,Ltd
13.10. Algae Health Sciences
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

❖ 世界の天然アスタキサンチン市場に関するよくある質問(FAQ) ❖

・天然アスタキサンチンの世界市場規模は？
→DataM Intelligence社は2023年の天然アスタキサンチンの世界市場規模を0.84億米ドルと推定しています。

・天然アスタキサンチンの世界市場予測は？
→DataM Intelligence社は2031年の天然アスタキサンチンの世界市場規模を15億米ドルと予測しています。

・天然アスタキサンチン市場の成長率は？
→DataM Intelligence社は天然アスタキサンチンの世界市場が2024年～2031年に年平均7.7%成長すると予測しています。

・世界の天然アスタキサンチン市場における主要企業は？
→DataM Intelligence社は「Algalif、Cyanotech Corporation、AstaReal、Valensa International、Atcama BIO、Algatech LTD、Piveg、Cardax、Inc、Xi'an Healthful Biotechnology Co.など ...」をグローバル天然アスタキサンチン市場の主要企業として認識しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。